In situ hybridization |
Identify EBER transcripts or EBV DNA in specific cell types within histologic lesions |
EBV clonality assay by Southern blot analysis |
Assess clonality of lesions with respect to EBV DNA structure; distinguish latent from replicative infection based on the episomal versus linear structure of the EBV genome |
EBV DNA amplification |
Detect viral DNA in patient tissues; disease specificity is lacking |
EBV viral load |
Quantitate EBV DNA in blood or body fluids to monitor disease status over time |
Immunohistochemistry (LMP1, EBNA1, EBNA2, LMP2A, BZLF1) |
Identify EBV protein expression in specific cell types within histologic lesions; distinguish latent from replicative infection based on expression profiles |
Culture of EBV or of EBV-infected B lymphocytes |
Detect and semiquantitatively measure infectious virions or latently-infected B lymphocytes; impractical for routine clinical use |
Electron microscopy |
Identify whole virions representing replicative viral infection; impractical for routine clinical use |
Serology (VCA, EBNA, EA, heterophile antibodies) |
Measure antibody response to viral proteins in serum samples; distinguish acute from remote infection; monitor disease status over time |